Related Experiment Videos
A new genetically obese-hyperglycemic rat (Wistar fatty)
Diabetes
|December 1, 1981
Summary
Congenic Wistar fatty rats (fa/fa) developed obesity and related metabolic issues, similar to Zucker fatty rats. Male rats showed diabetes symptoms due to WKY rat insulin resistance interacting with fa-induced obesity.
Area of Science:
- Genetics and Physiology
- Metabolic Disease Research
Background:
- The fa-gene, responsible for obesity in Zucker rats, was transferred to Wistar Kyoto (WKY) rats.
- This created a congenic strain, Wistar fatty rats (fa/fa), to study obesity and related conditions.
Purpose of the Study:
- To investigate the development of obesity and related metabolic disorders in the WKY congenic strain.
- To determine the impact of the fa-gene on WKY rat physiology, particularly concerning diabetes.
Main Methods:
- Transfer of the fa-gene from Zucker rats to WKY rats through 10 generations of backcrossing.
- Phenotypic analysis of Wistar fatty rats (fa/fa) for obesity, hyperinsulinemia, hyperlipemia, hyperglycemia, glucosuria, and polyuria.
- Assessment of glucose tolerance and insulin response in male rats of advancing age.
- Comparison of insulin sensitivity between WKY and Zucker rats using glucose tolerance tests and steady-state blood glucose methods.
Main Results:
- Wistar fatty rats (fa/fa) exhibited obesity and related features (hyperinsulinemia, hyperlipemia) comparable to Zucker fatty rats.
- Male Wistar fatty rats, but not females, developed hyperglycemia, glucosuria, and polyuria by 8 weeks of age.
- Decreased glucose tolerance and insulin response were observed in aging male rats.
- WKY rats demonstrated lower insulin sensitivity than Zucker rats, suggesting a predisposition to diabetes.
Conclusions:
- The Wistar fatty rat (fa/fa) serves as a valuable congenic model for studying obesity and associated metabolic diseases.
- Diabetic changes in this model result from an interaction between the inherent insulin resistance of WKY rats and fa-gene-induced obesity.
- The findings highlight the complex interplay between genetic background and specific gene effects in the development of metabolic syndrome.